US Patent

US11872314 — Pharmaceutical compositions

Formulation · Assigned to Shin Nippon Biomedical Laboratories Ltd · Expires 2037-08-04 · 11y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical powder compositions and methods of making them, assigned to Shin Nippon Biomedical Laboratories Ltd.

USPTO Abstract

Disclosed herein are pharmaceutical powder compositions, methods of making such compositions, and uses thereof.

Drugs covered by this patent

dihydroergotamine-mesylate (DIHYDROERGOTAMINE MESYLATE)

Patent Metadata

Patent number: US11872314
Jurisdiction: US
Classification: Formulation
Expires: 2037-08-04
Drug substance claim: No
Drug product claim: Yes
Assignee: Shin Nippon Biomedical Laboratories Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.